arsenic trioxide has been researched along with dehydroascorbic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gokhalé, P; Morrison, MJ; Patel, T; Vissers, MC | 1 |
Das, AS; Karmakar, S; Maiti, A; Majumdar, S; Mitra, C; Mukherjee, M; Mukherjee, S; Nanda, A | 1 |
2 other study(ies) available for arsenic trioxide and dehydroascorbic acid
Article | Year |
---|---|
The effect of intracellular ascorbate on the susceptibility of HL60 and Jurkat cells to chemotherapy agents.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Ascorbic Acid; Caspases; Cell Count; Dehydroascorbic Acid; Drug Resistance, Neoplasm; Etoposide; HL-60 Cells; Humans; Jurkat Cells; Melphalan; Oxides | 2006 |
Folic acid or combination of folic acid and vitamin B(12) prevents short-term arsenic trioxide-induced systemic and mitochondrial dysfunction and DNA damage.
Topics: Animals; Antioxidants; Arsenic Poisoning; Arsenic Trioxide; Arsenicals; Biomarkers; Catalase; Chemoprevention; Dehydroascorbic Acid; DNA Damage; Drug Therapy, Combination; Folic Acid; Glutathione; Islets of Langerhans; Lymphocytes; Male; Mitochondria; Nitrites; Oxidative Stress; Oxides; Rats; Superoxide Dismutase; Vitamin B 12 | 2009 |